UnitedHealth Group Incorporated (UNH)
UnitedHealth: 3 Key Takeaways for Long-Term Investors
AI chart summarization expanded to 40% of clinicians, cutting review time by 33%. UnitedHealth will reduce total prior authorizations by 30% by year end.
UnitedHealth: Q3 Confirms The Bull Case
UnitedHealth Group delivered strong Q3 results, with operating earnings up over 50% YoY and raised full-year guidance. Margin recovery at Optum Health and AI-driven efficiencies present significant upside, with management targeting 6%-8% Optum Health margins by 2028. Medicare Advantage margins are improving, Medicaid is stabilizing, and commercial insurance is being repriced to reflect higher costs.
From Verizon to UnitedHealth, Corporate America Is Balking at ‘Tokenized' Stocks
Broadcom and other companies have objected to tokenizing their shares under a new regulatory framework.
UnitedHealth's Q3 Margins Improve, But Membership Falls: Time to Buy?
UNH's Q3 earnings surge and improving margins signal a recovery, but falling membership and elevated utilization raise questions about sustained growth.
UnitedHealth Fell 51.32%, Then Rose 40.64%. DIA's Exposure Followed Both Moves by Design
UnitedHealth's wild ride inside DIA was not an accident or a manager's call.
Can UNH's Focus on Special Needs Plans Strengthen Medicare Growth?
UnitedHealth's focus on special needs plans, expanded Medicare coverage and improved margins could drive targeted growth in 2027 despite cost challenges.
UnitedHealth Group FQ3 Earnings: Positives Already Priced In
UnitedHealth Group Incorporated raised its full-year 2026 adjusted EPS guidance to at least $20.50 in its FQ3 2026 earnings report. With this updated guidance, Wall Street estimates for UNH could be conservative, creating the possibility of a upside surprise. However, despite operational progress, profit margins remain well below historical averages and could limit upside in the next ~2 years.
UnitedHealth Beats on Earnings, But Investors Question Growth Path
For the third consecutive quarter, UnitedHealth Group NYSE: UNH delivered a beat on both its top and bottom lines. But, as with the company's Q2 2026 report, investors gave the news a lukewarm response.
UnitedHealth Is Earning More From Less
Q3 adjusted EPS surged 61% to $4.69, while UnitedHealth raised its 2026 adjusted EPS outlook to at least $20.50. Medical care ratio improved 150 basis points to 88.4%, although favorable reserve development contributed approximately 70 basis points. Nine-month operating cash flow reached $25.1 billion, supporting the view that earnings improvement extends beyond accounting adjustments.
UnitedHealth is Down Big Over 3 Months: A Big Bank Says 40% Gains to Come After Raising Their Target
UnitedHealth has shed members, slipped 10% in three months, and closed lower on a beat-and-raise quarter.
UNH Q3 Earnings Call Highlights 2027 Growth and Margin Recovery
UnitedHealth raises its 2026 earnings outlook and targets stronger 2027 growth, even as commercial medical costs and Medicaid pressures challenge margin recovery.
UnitedHealth Group (UNH) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
